期刊文献+

糖尿病人乙酰化代谢表型研究 被引量:1

ACETYLATOR PHENOTYPING IN CHINESE POPULATION WITH DIABETES MELLITUS
下载PDF
导出
摘要 以咖啡因为代谢探针,研究汉族人群糖尿病(DM)及慢性并发症与N-乙酰化表型间的相关性。Ⅰ、Ⅱ型DM组快乙酰化代谢表型的频率分别为92.3%和87.8%,高于健康人群的73.4%,比值比(OR)分别为4.35与2.61。乙酰化代谢表型分布有或无慢性并发症无显著差异。快乙酰化代谢表型患者有神经病变或心脏病变组AFMU/1X均值显著低于无相应病变组,与年龄、发病年龄、病程呈显著负相关,与血果糖胺水平呈显著正相关。快乙酰代谢表型可能为汉族人群DM的遗传易感因素。患者年龄、发病年龄。 To examine the relationship between diabetes mellitus(DM,type Ⅰ and Ⅱ)or its chronic complications and acetylator phenotypes in Chinese population and clarify whether the acetylator status could be a genetic susceptible factor for DM or its chronic complications. A total of 108 Chinese diabetics were included. Significant differences in the proportion of fast or slow acetylators were observed between typeⅠ(92.3% or 7.7%) or type Ⅱ (87.8% or 12.2%) DM and control (73.4% or 26.6%). The odds ratio (OR) was 4.35 and 2.61 for fast acetylators or 0.23 and 0.38 for slow ones respectively. The mean AFMU/1X was lower in fast acetylators with neuropathy or cardiopathy than in those without them. Linear correlation of acetylation rate upon age, onset -age,clinical course and plasma fructosamine level in fast acetylators was observed but not in slow acetylators. The acetylate status may be one of the genetic factors that influence the susceptibility to diabetic neuropathy or diabetic cardiopathy, and change with age, onset-age,clinical course or blood fructosamine level in some way.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 1998年第3期146-149,共4页 The Chinese Journal of Clinical Pharmacology
基金 卫生部1996年立项课题
关键词 糖尿病 乙酰化代谢表型 咖啡因 NAT2 Diabetes mellitus acetylation phenotype caffeine
  • 相关文献

同被引文献25

  • 1谢红光,周宏灏.药物乙酰化遗传多态性的现状与展望[J].湖南医学,1993,10(3):159-160. 被引量:3
  • 2谢红光,周宏灏.中国主要民族药物乙酰化能力的遗传流行特征[J].药物流行病学杂志,1995,4(2):87-89. 被引量:4
  • 3Guo RC,Sun RP, Cui X.Distribution of N-acetylate phenotype in Chinese children and its relationship with down's syndrome and duchenne muscular dystrophy.Chin J Clin Pharmacol Ther,1999;4(1):17
  • 4Guo RC,Wolfgang T, Bernhard L.The relationship between high incidence of adverse dapsone reaction in Aids patients and slow acetylator phenotype or low plasma/lymphocytes glutathione level of these patients. Chin Med J (Engl),1996;109(12):933
  • 5Lee BL. Adverse reactions to trimethoprim-sulfamethoxazole. Clin Rev Allergy Immunol,1997; 14(4):451
  • 6Schops W, Prior V, Golka K, et al. Clinical relevance of acetylator phenotyping in 196 urothelial tumor patients. Urologe A,1997; 36(1):64
  • 7Weber WW. N-acetylation phamacogenetics. Pharmacol Rev,1985;37:25
  • 8Risch A, Wallace DM, athers S, et al. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet,1995; 4(2):231
  • 9Kloth MT, Gee Rl, Messing EM, et al. Expression of NAT in cultured human uroepithelial cells. Carcinogenesis,1994; 15(12):2781
  • 10Graf T, Broly F, Hoffman F, et al. Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers. Eur J Clin Pharmacol,1992;43:399

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部